StockData
Viatris Inc logo

Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)

Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%

Viatris operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Viatris's operating cash flow for the twelve months ending Jun 30, 2026 was $2.33B, up 12.9% year over year. For fiscal 2025 it was $2.32B, up 0.6% from the year before. The highest annual figure on record is $3.02B in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.32B+0.6%
FY2024Dec 31, 2024$2.30B-20.6%
FY2023Dec 31, 2023$2.90B-3.3%
FY2022Dec 31, 2022$3.00B-0.6%
FY2021Dec 31, 2021$3.02B+144.9%
FY2020Dec 31, 2020$1.23B-31.7%
FY2019Dec 31, 2019$1.80B-23.0%
FY2018Dec 31, 2018$2.34B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$381.80M+73.8%
Q1 FY2026Mar 31, 2026$388.30M-27.5%
Q4 FY2025Dec 31, 2025$815.80M+69.0%
Q3 FY2025Sep 30, 2025$744.90M-9.9%
Q2 FY2025Jun 30, 2025$219.70M-42.0%
Q1 FY2025Mar 31, 2025$535.50M-12.9%
Q4 FY2024Dec 31, 2024$482.70M-15.1%
Q3 FY2024Sep 30, 2024$826.50M-1.0%
Q2 FY2024Jun 30, 2024$379.10M-27.8%
Q1 FY2024Mar 31, 2024$614.60M-36.7%
Q4 FY2023Dec 31, 2023$568.50M+200.8%
Q3 FY2023Sep 30, 2023$835.20M-3.9%
Q2 FY2023Jun 30, 2023$525.10M-34.6%
Q1 FY2023Mar 31, 2023$971.20M-14.7%
Q4 FY2022Dec 31, 2022$189.00M-63.9%
Q3 FY2022Sep 30, 2022$869.00M-20.0%
Q2 FY2022Jun 30, 2022$802.50M+43.5%
Q1 FY2022Mar 31, 2022$1.14B+34.1%
Q4 FY2021Dec 31, 2021$523.10M+1345.0%
Q3 FY2021Sep 30, 2021$1.09B+106.8%
Q2 FY2021Jun 30, 2021$559.40M+47.4%
Q1 FY2021Mar 31, 2021$848.80M+191.6%
Q4 FY2020Dec 31, 2020$36.20M–
Q3 FY2020Sep 30, 2020$525.00M–
Q2 FY2020Jun 30, 2020$379.50M–
Q1 FY2020Mar 31, 2020$291.10M–

More Viatris figures

See a number that looks wrong?